An artificial intelligence (AI) model trained on data from whole slide images (I), clinical features (C), and enhanced molecular analysis (M+) from the phase 3 TAILORx study (NCT00310180) showed better prognostic value for recurrence compared…
Multimodal AI Model Prognostic for Long-Term Recurrence Following Treatment for Early Breast Cancer
